Gijs van de Wetering
Gijs van de Wetering publishes mostly in Economics and Econometrics, Cardiology and Cardiovascular Medicine and General Health Professions, on topics such as Health Systems, Economic Evaluations, Quality of Life, Chronic Lymphocytic Leukemia Research and Pharmaceutical Economics and Policy.
- World rank
- #4,444,250 of 7,710,434 ranked researchers
- Rank in Netherlands
- #82,455 of 107,149
- Works
- 51
- Citations
- 284
- Citations per work
- 5.6
What does Gijs van de Wetering research?
Gijs van de Wetering's work is mostly in Economics, Econometrics and Finance (27%), Medicine (25%), Health Professions (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1734.1%
- Health Sciences1732.6%
- Medicine1324.8%
- Health Professions47.8%
- Social Sciences1427.1%
- Life Sciences36.2%
- 1Economics and Econometrics27% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3General Health Professions8% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Genetics6% of their works
- 6Immunology6% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Chronic Lymphocytic Leukemia Research
- Pharmaceutical Economics and Policy
- Psoriasis: Treatment and Pathogenesis
- Healthcare cost, quality, practices
- Heart Failure Treatment and Management
- Spondyloarthritis Studies and Treatments
- Healthcare Policy and Management
Which keywords describe Gijs van de Wetering's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Chronic Lymphocytic Leukemia, Genomic Aberrations, Drug Development Costs, Generic Drugs, IL-17 and TH17 Cells.
- Spondyloarthritis
- Insurance Markets
- Health Care Spending
- Choosing Wisely
- TH17 Cells
- Generic Drugs
- Genomic Aberrations
- Quality of Life
- Cost-effectiveness Analysis
- Chronic Lymphocytic Leukemia
- Drug Development Costs
- IL-17
- Ankylosing Spondylitis
- Guidelines
- Heart Failure
- Low-Value Care
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost-effectiveness Analysis211 topic
- Quality of Life211 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Drug Development Costs61 topic
- Generic Drugs61 topic
- IL-1751 topic
- TH17 Cells51 topic
- Ankylosing Spondylitis41 topic
- Choosing Wisely41 topic
- Guidelines41 topic
- Health Care Spending41 topic
- Heart Failure41 topic
- Insurance Markets41 topic
- Low-Value Care41 topic
- Spondyloarthritis41 topic
Where does Gijs van de Wetering work?
Gijs van de Wetering's main affiliation in the publication record is Pharmerit (Netherlands), Netherlands.
How many publications and citations does Gijs van de Wetering have?
OpenAlex counts 51 works and 284 citations for Gijs van de Wetering, an h-index of 10, ranking #4,444,250 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gijs van de Wetering. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.